State of New Jersey Common Pension Fund D Acquires 12,421 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

State of New Jersey Common Pension Fund D lifted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 423,480 shares of the pharmacy operator’s stock after buying an additional 12,421 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Walgreens Boots Alliance were worth $11,057,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its position in Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares during the period. Highlander Capital Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $26,000. Venturi Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. FinTrust Capital Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 2,314.5% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,273 shares during the period. Finally, Rocky Mountain Advisers LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $30,000. Institutional investors own 58.59% of the company’s stock.

Insider Transactions at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders purchased 13,456 shares of company stock worth $270,423 over the last three months. 17.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. TD Cowen dropped their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, April 3rd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday, April 1st. TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Finally, HSBC reaffirmed a “reduce” rating and issued a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Stock Down 1.2 %

NASDAQ:WBA traded down $0.21 on Thursday, reaching $17.60. 7,851,867 shares of the stock traded hands, compared to its average volume of 13,908,103. The company has a market capitalization of $15.18 billion, a price-to-earnings ratio of -2.54, a PEG ratio of 1.12 and a beta of 0.73. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a 12 month low of $17.51 and a 12 month high of $35.38. The company’s fifty day simple moving average is $20.19 and its 200 day simple moving average is $21.84.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business earned $1.16 EPS. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.